These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Incidence and pathophysiology of peptic ulcer bleeding. Arlt GD; Leyh M Langenbecks Arch Surg; 2001 Mar; 386(2):75-81. PubMed ID: 11374051 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents. Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866 [TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding. Chung WC; Jeon EJ; Kim DB; Sung HJ; Kim YJ; Lim ES; Kim MA; Oh JH World J Gastroenterol; 2015 Jul; 21(28):8636-43. PubMed ID: 26229405 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of bleeding peptic ulcers: a prospective study. Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885 [TBL] [Abstract][Full Text] [Related]
33. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori. Chason RD; Reisch JS; Rockey DC Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535 [TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers. Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566 [TBL] [Abstract][Full Text] [Related]
35. Prospective survey for the etiology and outcome of peptic ulcer bleeding: a community based study in southern Taiwan. Chang CY; Wu MS; Lee CT; Hwang JC; Tai CM; Perng DS; Lin CW; Wang WL; Wang JD; Lin JT J Formos Med Assoc; 2011 Apr; 110(4):223-9. PubMed ID: 21540004 [TBL] [Abstract][Full Text] [Related]
36. Letter: peptic ulcer bleeding in patients with cirrhosis. Musumba C Aliment Pharmacol Ther; 2012 Sep; 36(6):597-8; author reply 598. PubMed ID: 22913844 [No Abstract] [Full Text] [Related]
37. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study. Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993 [TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215 [TBL] [Abstract][Full Text] [Related]
39. Low dose aspirin, H. pylori infection, and the risk of upper gastrointestinal bleeding. Sostres C; Lanas A Med J Aust; 2018 Sep; 209(7):297-298. PubMed ID: 30257631 [No Abstract] [Full Text] [Related]
40. Helicobacter pylori and acute bleeding peptic ulcer. Henriksson AE; Edman AC; Held M; Wadström T Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):769-71. PubMed ID: 7496867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]